AI Selloff: Should Investors Buy the Dip or Shift to Value Stocks? Jun 8, 2026 Financial Service, Technology
Two Beaten-Down Pharma Giants: Biotech’s Cyclical Turn Delivers Prime Dip-Buy Opportunities Jun 4, 2026 Life Science
Cameco Boosts Cigar Lake Holdings, Contrarian Investment Opportunity Emerges Jun 1, 2026 Energy Metals
Plunging Over 20%: Do Two Canadian Dividend Stocks Offer Compelling Contrarian Opportunities? May 28, 2026 Financial Service
Beyond Lilly and Novo Nordisk: Two Under-the-Radar Picks in the Obesity Drug Market May 26, 2026 Life Science
Pfizer’s 50% Stock Crash: A Hidden Contrarian Buy Amid Booming Healthcare Sector May 22, 2026 Life Science
Is It Time to Buy the Dip in Surgical Robotics Leader Intuitive Surgical (ISRG)? May 14, 2026 Life Science
Can Novo Nordisk Stage a Turnaround on Wegovy Data and Robust Drug Pipeline? May 13, 2026 Life Science
3 Oversold Canadian Value Stocks to Buy Now Amid Market Divergence May 12, 2026 Consumer Goods, Energy, Financial Service
UnitedHealth Soars 36.9% in April, As Earnings Beat Unlocks Valuation Recovery Runway May 5, 2026 Financial Service, Life Science
American Express Trades Below 20 P/E — Is Buffett’s Second-Largest Bet Now a Steal? Apr 28, 2026 Financial Service
Starbucks Stock Has Run Hot, April 28 Will Show Whether the Turnaround Is Real Apr 22, 2026 Consumer Goods
